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Immunoglobulin A (IgA) associated glomerulonephritis. Ade-
quate tissue from 153 glomerulonephritic patients was examined
by direct immunofluorescence for glomerular-bound immuno-
globulins, MC, and fibrinogen. Ninety-six specimens contained
immunoglobulins; 15 (16%) that contained significant amounts
of IgA were from patients without systemic lupus erythematosus
or other identifiable systemic disease. IgA, usually visualized in
association with other immunoglobulins, was the most plentiful;
in three biopsies it was the only immunoglobulin. IgA deposition
was primarily mesangial, and to a lesser degree along peripheral
glomerular capillary loops; electron-dense deposits and cellular
proliferation also were principally mesangial in location. All
patients had persistent microhematuria, while seven had at least
one episode of gross hematuria; renal failure occurred in two
patients and nephrotic syndrome in one of them. No clinical
event was related to the onset of renal disease in these patients.
Although three had low circulating levels of MC, and three sera
were positive for rheumatoid factor, none had cryoglobulins,
antinuclear antibodies or abnormal immunoglobulin concentra-
tions. Sera tested by hemagglutination for antilgA antibodies
and biopsies tested for antilgG antibodies were negative. Eluates
from three needle biopsies failed to bind to normal human
kidney sections in vitro; an eluate from a nephrectomy organ
contained IgA which fixed weakly to non-basement membrane
intraglomerular components.
Glomérulonéphrite associée I l'immunoglobuline A (IgA). Du
tissu renal de 153 malades atteints de glomérulonèphrite a èté
examine en immunofluorescence pour détecter les immuno-
globulines le fMC et le fibrinogene déposés sur le glomérule.
Quatre vingt seize èchantillons contenaient des immunoglobu-
lines; 15 (16%) qui contenaient des quantités importantes d'IgA
provenaient de malades atteints de lupus érythémateux dissé-
mine ou d'autres maladies de système identifiables. L'IgA,
habituellement associée a d'autres immunoglobulines, était Ia
plus abondante. Dans trois biopsies elle était la seule immuno-
globuline. Les dépôts d'IgA étaient principalement mèsangiaux
et, it un moindre degré, le long des anses capillaires périphéri-
ques. Des dépôts denses en microscopie électronique et une
proliferation cellulaire étaient aussi principalement mèsangiaux.
Tous les malades avaient une hématurie microscopique per-
sistante, sept d'entre eux eurent au moms une hématurie macro-
scopique; deux malades eurent une insuffisanse rénale et un
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malade un syndrome néphrotique. Aucun événement clinique
n'était contemporain de l'installation de Ia néphropathie chez
ces malades. Quoique trois d'entre eux avaient des concentra-
tions basses de j3lC et que trois serum ètaient positifs pour le
facteur rhumatoide, aucun n'avait de cryoglobulines, d'anti-
corps antinucléaires ou de concentrations anormales d'immuno-
globuline. Les serums testes par hémaglutination pour les anti-
corps anti IgA et les biopsies testées pour les anticorps anti IgG
étaient négatifs. Les éluats de trois biopsies it l'aiguille ne se
sont pas déposés sur des coupes de rein humain normal in vitro.
Un eluat de rein néphrectomisé contenait de l'IgA qui s'est fixé
faiblement sur des constituants glomerulaires différents de Ia
membrane basale.
Investigation of experimental, immunologically mediated
glomerulonephritis has led to understanding that glomeru-
lar injury results from one of two pathogenetic mechanisms
[1]. The first is caused by antibodies with specificities
directed toward intrinsic antigenic determinants associated
with the glomerular basement membrane (GBM). The
second is caused by the fortuitous localization in glomeruli
of circulating immune complexes composed of non-glomeru-
lar basement membrane antigen and host antibodies.
Indications exist that human glomerulonephritis is caused
by similar immunopathogenetic mechanisms. Eluted host
immunoglobulin (Ig) from kidneys of patients with Good-
pasture's Syndrome and some cases of chronic glomerulo-
nephritis have shown anti-glomerular basement membrane
specificity for normal homologous GBM in vitro [2J and
for heterologous GBM in vivo and in vitro [3]; also eluted
host Ig from kidneys of patients with systemic lupus
erythematosus (SLE) has shown antibody specificity to
DNA [4].
Evidence has been offered that acute poststreptococcal
glomerulonephritis [5], and glomerulonephritis associated
with infected ventriculoatrial shunts [6, 7], bacterial
endocarditis [8, 9], secondary syphilis [10], malaria [11]
and infectious hepatitis [12] are also caused by circulating
complexes. Nevertheless, the pathogenesis of many forms
of glomerulonephritis encountered clinically remains
uncertain.
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The present study was undertaken to determine the
frequency of immunoglobulin deposition in renal tissue
obtained from a population of patients with clinical
glomerulonephritis. Attention was focused on immuno-
globulin A (IgA) because recent reports from France by
Berger [13], Berger, Yaneva and Antoine [14] and Druet
et al [15] suggested its frequent presence in biopsies from
nephritic patients. Our data indicate that IgA participates
in the renal disease of a significant number of glomerulo-
nephritic patients biopsied at our institution. Studies
designed to the test the role of IgA as antigen and as anti-
body in these patients were negative, although an eluate
from an IgA-nephritic kidney fixed weakly to the mesangium
of normal human kidney slices in ritro.
Methods
Satisfactory renal tissue for immunofluorescent micro-
scopic evaluation was available from 153 patients, obtained
by percutaneous renal biopsy, open renal biopsy or
nephrectomy in preparation for transplantation. The
tissue was snap-frozen in liquid nitrogen and stored at
_200 C. Subsequently, all tissue was stained with antisera
specific for immunoglobulins G, M and A, third component
of complement (f1C) and fibrinogen/fibrin.
Immuno fluorescent microscopy was done by the method
of Coons and Kaplan [16] as described previously [17],
using a Leitz Ortholux microscope, HBO 200 W light
source, UGI exciter filter and k460 barrier filter.
Routine light microscopy was performed on sections 2
to 4 ji in thickness from kidney specimens fixed in purified
paraformaldehyde or buffered 10% formalin, and embedded
in paraffin. Sections were stained with hematoxylin and
eosin (H&E), periodic acid Schiff (PAS) and Gomori's
trichrome reagents.
Electron microscopy was performed on an RCA, EMU 3F
electron microscope. Tissue was fixed in purified para-
formaldehyde, postfixed in osmium tetroxide, dehydrated
at 4° C through graded alcohols, embedded in Epon 812
and stained with uranyl acetate and lead citrate.
Antigen preparation. IgG was isolated from pooled human
sera. 1gM was obtained from the sera of patients with 1gM
myeloma. Sera were fractionated with ammonium sulfate
at half-saturation and the specific immunoglobulins
separated by Pevikon block electrophoresis and diethyl-
aminoethyl (DEAE) cellulose chromatography. IgA was
obtained from the serum of a patient with IgA myeloma.
Following ammonium sulfate fractionation, euglobulin was
precipitated by dialysis against Sorensen's buffer and the
supernatant chromatographed on DEAE cellulose using
a potassium phosphate gradient between 0.01 M and 0.30M,
pH 8.0; the recovered IgA then was chromatographed on
Pevikon [18]. Pure human C' 3 component of complement
was the gift of Hans J. Muller-Eberhard. Human fibrinogen-
fibrin was prepared by the method of Kekwick et al [19].
Antisera preparaion. Antisera to the specific antigens
were raised in New Zealand white rabbits. Initial rear
footpad injections of 1 mg of the protein emulsified in
Freund's incomplete adjuvant were followed by weekly
or two weekly subcutaneous injections of the same antigen;
bleedings were done seven days following a booster
injection.
Fluoresceination of all antisera globulin preparations was
performed according to the method of Clark and Shepard
[20]. Nonspecific fluorescence was removed by subsequent
chromatography on DEAE [3]. The antisera were tested
by immunoelectrophoresis (IEP) and double diffusion
analysis in agarose and shown to be monospecific for the
antigens described.
Immunodiffusion analysis was done by the method of
Ouchterlony in glass dishes, using agarose 0.5%, pH 8.2,
mt= 0.04.
Quantitative immunodiffusion for serum IgG, IgA, 1gM
and 31C (third component of complement) was done by
the Mancini technique [21], utilizing immunodiffusion
plates (Hyland Division of Travenol Laboratories, Inc.,
Costa Mesa, California).
Immunoelectrophoresis was done on glass slides in 1 %
agarose using barbital buffer, mj.i 0.04, pH 8.6 at 5 volts/cm2
for 45 minutes.
Rheumatoid sheep cell agglutination and serum antilgA
agglutination were performed by the method of Heller et al
[22] using microtiter plates. Chromic chloride was used
to couple IgA to sheep red blood cells [23].
Antinuclear antibody (ANA) activity in the patients' sera
was tested by fluorescent microscopy on fresh mouse liver
snap-frozen in liquid nitrogen and fixed in ether-alcohol
(50: 50). Sera were tested with fluoresceinated antihuman
fraction II and antihuman IgA.
Cryoglobulins. Patients' sera, drawn and separated at
37° C, were observed at 4° C for five days for the formation
of cryoprecipitates. Plasma from one patient also was
examined for cryofibrinogen.
Routine chemistry. Serum electrophoresis was done on
cellulose acetate membranes using a Beckman microzone
cell; scanning was done on a Beckman microzone densito-
meter. Total serum proteins were determined by the Biuret
method [24] and blood chemistry analyses were performed
on a Teclmicon Autoanalyzer. Urinary protein concentra-
tion was determined with trichloroacetic acid [25] using
aliquots of urine from 24-hour collections. Turbidity was
read at 420 mt on a microspectrophotometer (Gilford
Laboratories, Model 300N).
Elution from renal tissue. Antibody elutions were per-
formed from three needle biopsies (L.K., J.K., W.W.)
and from one nephrectomy sample (W. G.), using 0.02 M
citric acid buffer, pH 3.2 [3]. Eluates from the needle
biopsies were dialyzed against phosphate-buffered saline,
concentrated to a single drop and tested by indirect
fluorescence for fixation to human kidney sections, testing
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with fluorescein conjugated antihuman IgA. The eluate
from the nephrectomy specimen was concentrated to an
IgA concentration of 1.15 mg/mi and tested similarly,
using fluorescein conjugated antihuman IgA, M and G.
Results
Frequency of immunoglobulin detection
During the period of the study, kidney tissue from
153 patients was adequate for evaluation by fluorescent
microscopy. Immunoglobulins G, M or A either singly
or in combination were detected in the glomeruli of 96
(63%) of these specimens. Glomerular localization of IgG
was present in 68 (70%), 1gM in 42 (44%) and IgA in
35 (36%).
Seven of the 35 patients whose glomeruli contained IgA
had systemic lupus erythematosus (SLE); two others had
anti-glomerular basement membrane antibody-mediated
glomerulonephritis as inferred by a linear fluorescent
staining pattern for host Ig along capillary basement
membranes. Eleven other patients had trace amounts of
IgA in their glomeruli and will not be considered further.
The remaining 15 patients (16% of those with glomerular
localization of immunoglobulins) had large amounts of
IgA localized to glomeruli; these patients had no clinical
or laboratory evidence of other known systemic diseases
and are the subjects for this report.
Immunohistochemical characteristics of biopsies from patients
other than SLE, containing large amounts of IgA
IgA was the only immunoglobulin detected in the biopsies
from three patients (W.G., B.R., L.K.; Table 1). In two
patients (W.F., D.S.), IgG was also present, and in ten
patients both IgG and 1gM were present.
fllC was detected in the biopsies of 13 patients, 12 of
which also contained IgG. In one patient, L.K., IgA was
the only immunoglobulin detected in association with f3lC.
Fibrinogen was present in ten specimens.
All immunoglobulins, J3lC and fibrinogen were found
in the mesangium of glomeruli (Figs. 1 and 2). In eleven
cases, mesangial deposition was predominant, in three
cases mesangial and capillary loop deposition appeared
equal, and in one patient peripheral capillary ioop de-
position was predominant. Quantitatively, the degree of
protein deposition varied from glomerulus to glomerulus,
but all glomeruli were involved.
Histopathologic studies
Light microscopy. Sixteen renal specimens from 15 pa-
tients were examined by routine light microscopy (Table 2)
Table 1. Glomerular localization of immunofluorescent stains
Fibrin-
IgA IgG 1gM 31C ogen/ Distribution
fibrin
W.G. 2+ 0 0 0 0 Mesangium
B.R. 2+ 0 0 0 1—2+ Mesangium
L.K. 3+ 0 0 1—2+ focal Mesangium
lobules
W.F. 2+ Tr—l+ 0 Tr 0 Mesangium
D.S. 3+ Tr—l+ 0 Tr—l+ 2—3+ Mesangium+
Loop
L.F. 2+ 3+ 2+ 2+ 0 Mesangium +
Loop
P.C. 2—3+ 1—2+ Tr 2+ 0 Mesangium
R.S. 2+ 1—2+ 1+ 1—2+ 0 Mesangium
J.K. 3+ 3+ 3+ 3+ 2—3+ Mesangium+
Loop
J.S. 2+ 2+ 2+ rare Tr Mesangium
A.A. 3+ 2+ 1+ 2+ 3+ Mesangium
H.B. 3+ 3+ 1+ 1+ 1—3+ Capillaryloops,
some
mesangium
S.E. 4+ 2+ 1—2+ 2+ 4+ Mesangium
W. W. 3—4 + 1 + rare rare Tr Mesangium
E.M. 2—3+ Tr 2—3+ 2+ Tr—2+ Mesangium
Tr = trace.
using the semiquantitative methods and terminology of
Pirani and Salinas-Madrigal [26]. Patient W. G.'s kidney
was "end stage" and is omitted from further description.
The remaining biopsies were adequate for interpretation
and contained S to 30 glomeruli. In the biopsy with five
glomeruli the changes involved all glomeruli and it was
assumed these glomeruli were typical of the remainder of
the kidney.
The most prominent alterations noted were mesangial
cell hypercellularity and increased PAS-positive mesangial
matrix material (Figs. 3 A, 3 B and 4). These changes were
generalized in all 15 specimens, but frequently the degree
of involvement varied among glomeruli or individual
lobules of a single glomerulus. Segmental foci of circum-
ferential mesangial interposition giving the appearance of a
double basement membrane was observed in several
glomeruli of three patients (Fig. 4), but was not extensive
enough to be confused with membranoproliferative
glomerulonephritis [27]. Minimal thickening of the base-
ment membrane, segmental in distribution, was seen in
seven specimens. Endothelial (nine patients) and epithelial
(four patients) cell proliferation were usually mild. Patency
of the capillary lumens was dependent primarily on the
severity of the mesangial changes.
The glomeruli of eight patients demonstrated a slight
increase in prominence of lobules, a change which cor-
related with the severity of mesangial alterations, in
patient R. S. prominence of lobules developed over a
three-year period without clinical decrement in renal
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Fig. 1. Patient W. W. Diffuse staining of mesangium with fluo- Fig. 2. Patient R. S. Segmental staining of mesangium with
resceinated antihuman IgA (x 350). fluoresceinatedintihuman IgA (X350).
Table 2. Patterns of histological alteration
Cellular proliferation Fibro- Increased Focal Narrowed Tendency PMNs Per cent Total
epithelial mesangial thickening capillary toward per hyalinized glomerular
Endo- Mes- Epi- crescents matrix basement lumens lobule glomer- glomeruli damagea
thelial angial thelial membrane formation ulus
B.R. 1+ 1—2+ 0 0 1—2+
L.K. 1+ 2+ 0 0 1+
W.F. 0 1—2+ 0 0 1—2+
D.S. 1+ 2+ 0 0 2+
L.F. 0 1+ 0 0 1—2+
P.C. 1+ 2+ 1+ 15% of 1-2+
glomeruli
R.S. 1+ 1—2+ 0—1+ 20% of 1—2+
1968 glomeruli
R.S. 1+ 2+ 1+ 0
1971
J.K. 1+ 2+ 0 0
J.S. 1+ 1—3+ 0 0
A.A. 0 1—2+ 0 0
H.B. 1+ 2-4+ 0-3+ 30% of
glomeruli
S.E. 0 1+ 0 0
W.W. 0 1+ 0 0
E.M. 0—1+ 0—3+ 0 0
1+S 1+S 0—2+
0 1+ 1+
CM1,S 0—2+S 1+
0 1+ 0
0 1+S 0
0 1—3+ 0
0 1—2+ 0
1 20 1—2+
1 0 1+
1—2 30 1+
1 0 1+
1 0 1+
1 0 2+
1 0 2+
1 20 2+
1 25 1—3+
1 20 1+
2—3 30 3+
S = focal and segmental; CMI = circumferential mesangial interposition; PMNs = polymorphonuclear leucocytes.
a Scored on nonhyalinized glomeruli.
b Mesangial deposits on Gomori's trichome.
2_3+b CMI,S 2+ 1+ 1 0 3+
2+°
1-3+
1-2+
2-4 +
1+
1+
0-3 +
2+,S 2+
0 1—4+
CMI,S 0—1+S
2+,S 2—4+
0 0
0 1+
0—1+ 0—3+
0
0-3+
1+
0-3 +
0
0
0-2+
1 0 +1/2
1 20 1+
1 0 0—3+
4.
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Fig. 3A. Fig. 3B.
Fig. 3 A. Patient J. K. Mild diffuse increase in mesangial matrix
with segmental mesangial hypercellularity (H &E X 400).
B. Patient J. K. Moderate diffuse increase in mesangial matrix
with minimal mesangial hypercellularity (PAS x 400).
Fig. 4. Patient A. A. Segmental mesangial hypercellularity
(PAS x400); circumferential mesangial interposition (insert,
PAS x 1325). Fig. 4.
2 
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function. Sclerotic mesangial nodules as described in
lobular glomerulonephritis were not seen [27].
Small fibro-epithelial crescents were seen in three
biopsies (P.C., R. S., H. B.). In patient R. S. crescents were
not observed on the second biopsy, although more extensive
glomerular changes were present.
A significant number of hyalinized glomeruli were
present in biopsies from seven patients. Polymorphonuclear
leukocyte infiltration of glomeruli was minimal.
Interstitial, vascular and tubular changes were minimal
except in two cases. Patient H. B.'s biopsy showed a diffuse
interstitial inflammatory response consisting of poly-
morphonuclear leukocytes, eosinophils and monocytes;
patient B. R.'s biopsy showed mucinous intimal fibrosis
Fig. 5. Electron dense deposits in mes-
angium of kidney ( x 22,610). D, deposit;
BM, basement membrane; arrow, uri-
nary space; M, mesangium.
of interlobular arteries and hyalinization of afferent arteri-
oles without fibrinoid necrosis.
Electron microscopy. Seven biopsies were studied. In
five (D.S., L.F., J.K., J.S., S.E.), small granular electron-
dense deposits were present between the mesangial cells and
the axial basement membrane (Fig. 5). In patient J.K.
subendothelial and subepithelial deposits were present
along peripheral capillary loops in addition to the more
extensive mesangial deposits. In those biopsies containing
large quantities of IgG, electron-dense deposits were
numerous, while in those containing small quantities of
IgG, deposits were few. No deposits were present in the
biopsies of two patients (W.G., L.K.) in whom IgA was
the only immunoglobulin present.
IgA associated glomerulonephritis 173
Clinical characteristics of Patients with IgA associated
glomerulonephritis: Initial presentation
Eight of the 15 patients presented with microhematuria
at the time of a routine urinalysis. Historically, four others
had experienced a single episode of gross hematuria and
were observed to have persistent microhematuria. Of the
remaining three patients, one presented with recurrent
gross and persistent microhematurja (R. S.), one with
accelerated hypertension and microhematuria (B. R.) and
one with a history of chronic renal disease manifested by
urinary tract infections, proteinuria and a mildly elevated
blood urea nitrogen (W. G.). No patient had a documented
history of streptococcal infection immediately preceding
the onset of his disease.
The average time to renal biopsy from the known onset
of the clinical abnormalities was 17 months with a range
of one month to eight years.
Clinical evaluation at the time of renal biopsy
The average age of the patients was 27 years (Table 3).
There were 11 men and four women. Four patients had
diastolic blood pressures of 90 mm Hg or greater. Renal
function was abnormal in two patients as inferred from a
consistent serum creatinine concentration greater than
1.5 mg/100 ml.
Microhematuria in excess of 3 RBC/hpf was found in all
patients, and 11 patients had red blood cell and/or granular
casts in the urine sediment. Proteinuria was detected on a
routine urinalysis of 14 Patients, and 13 had 24-hour urine
protein excretions in excess of 100 mg;
the nephrotic syndrome.
patient H.B. had
Structural abnormalities were not observed on intra-
venous urography in any of the patients, although the two
patients with impaired renal function demonstrated a
decrease in concentration of the contrast media.
Urine cultures were negative in all but one patient (J. S.).
Patient W. G., who related a history of urinary tract
infections prior to being evaluated, had negative urine
cultures.
Serologic evaluation at the time of biopsy
Normal antistreptolysin-0 titers were measured in the
11 patients so tested (Table 3). Rheumatoid sheep cell
agglutination titers were mildly elevated in three patients
(J.K., J.S., S.F.) of the 15 tested. No patient had a clinical
history compatible with rheumatoid arthritis.
Serum concentrations of immunoglobulins 0, M, and A
were normal in fourteen patients; patient W. F. had a mild
elevation of his serum IgA concentration. The third com-
ponent of complement (l3lC), measured by immuno-
diffusion, was depressed in two patients (E.M., W.W.)
and was immeasurably low in another (J. K.). No patient
had detectable antinuclear antibody activity in his serum.
Sera from all patients were tested by hemagglutination
for antibody activity against human IgA, and none was
detected. Cryoglobulins were not detected in the sera of
six patients tested; cryofibrinogen was not detected in one
plasma (W. G.).
Testing of eluates. The IgA concentration in W. G.'s
eluate was 115 mg/ml; IgG and 1gM concentrations were
undetectable. The other three eluates, too limited to
permit quantitative protein analyses, were tested only by
indirect immunofluorescence.
Table 3. Clinical data at time of renal biopsy
Age Sex Hematuriaa
Gross Micro
Proteinuria
g/24 hr
Serum
Creatinine
mg/100 ml
BUN
mg/100 ml
Rheumatoid
Factor
Complement '
mg/100 ml
Cryoglobulins
W.G. 57 M + 0.30 15.0 100 0 115 Negative
B.R. 24 M + 1.70 1.4 24 0 160 N.D.
L.K. 51 F + 0.40 1.0 10 0 205 N.D.
W.F. 53 M + 0.50 1.3 19 0 140 Negative
D.S. 19 M + Trace 1.0 13 0 125 ND.
L.F. 19 M + + N.D. 1.4 ND. 0 130 ND.
P.C. 18 M + + 1.50 1.2 15 0 155 N.D.
R.S. 10 M + + 0.39 0.6 21 0 190 Negative
J.K. 17 M + + 0.14 1.1 17 1:112 Immeasurable Negative
J.S. 21 F + 2.20 1.1 22 1:56 210 N.D.
A.A. 17 F + + 0.46 1.2 10 0 135 Negative
H.B. 37 M + + 14.00 4.3 60 0 147 Negative
S.F. 21 M + + 0.50 ND. 16 1:56 115 N.D.
W.W. 21 M + 1.40 1.4 21 0 57 N.D.
F.M. 17 F + 0.58 0.9 14 0 77 N.D.
a During entire period of observation.
Normal complement = 90—225 mg/l00 ml.
N.D.= not done.
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In vitro testing on normal human kidney sections of the
kidney eluates from J.K., L.K., and W.F. revealed no
fixation to glomerular structures when studied with con-
jugated antisera to human IgA. There was weak but specific
fixation of eluate W. G. to mesangial components of human
kidney sections, detected with conjugated antihuman IgA
but not with antihuman IgG or 1gM. No fixation of
serum W. G. to normal human kidney could be demon-
strated utilizing the same reagents. The W. G. serum
utilized was drawn in the anephric state.
Clinical observation since biopsy
By history, patient P.C. experienced gross hematuria
one month following his biopsy and patients L.F. and
J.K. have experienced recurrent gross hematuria. A total
of seven patients, therefore, have had gross hematuria
during their illness.
Two patients, H.B. and W.G., have developed renal
failure; H.B. requires hemodialysis, and W.G. has re-
ceived a cadaver kidney allograft. The remaining six
patients have been followed for periods between four and
14 months; all have persistent microhematuria, proteinuria
and normal renal function. Patient B.R., who initially
presented with accelerated hypertension, requires minimal
antihypertensive medication at the present time.
Discussion
These 15 patients with generalized, glomerular-bound
IgA comprise 16% of our clinically nephritic population
whose renal biopsies have been found to contain immuno-
globulins. They are of interest for several reasons. First,
this is the only series of patients without systemic diseases
and with substantial glomerular localization of IgA to be
reported outside of France [13—15]. The report of com-
parable patients from such differing localities suggests that
obvious geographic and genetic factors or local environ-
mental antigens are not major contributors to the disease.
Second, the dominance of IgA as a participant in the
disease focuses attention on this class of immunoglobulins.
Although recognized as a principal effector of local im-
munity in external secretions, with few exceptions, IgA
has received little attention as a major effector of systemic
immunity [28, 29]. It seems unlikely that intact secretory
IgA has diffused from external passages into the circulation
of these patients. In support of this concept is the fact
that secretory piece1 has not been found in the kidneys
from five patients with IgA deposits [unpublished observa-
tions]. Normal serum immunoglobulin concentrations,
serum electrophoreses and the absence of cryoprecipitates
mitigate against glomerular-bound IgA in our cases being
Fluoresceinated antiserum to human secretory piece kindly
provided by Dr. Thomas Tomasi.
related to a paraproteinemia or a perversion of the IgA
synthetic system. Third, on clinical grounds 12 patients
could not be distinguished from patients having "benign
hematuria" [30—32] or recurrent hematuria with focal
glomerulonephritis [33—36]. By immunofluorescent micro-
scopy, however, it was clear that a generalized process was
operative in all cases despite the local variability of mes-
angial changes recognized in some biopsies by light
microscopy.
The specific immunopathogenetic role of IgA in these
patients is not clear. The presence of IgA could be a
secondary, passive phenomenon. However, IgA was the
only immunoglobulin demonstrated in the biopsies of
three patients, the distribution of this protein was constant
and not random in the biopsies from all patients, and the
clinical and histologic alterations were similar in all cases,
suggesting that IgA is present as a meaningful participant.
Second, the mesangial localization of IgA might be related
to a physiochemical alteration of the circulating protein,
and renal injury might be consequent to selective deposi-
tion. Experimentally, Michael, Fish and Good [371 demon-
strated that serum protein aggregates injected intravenously
into mice preferentially localize in the glomerular mes-
angium. Although an excess of dimeric or trimeric IgA
in the serum of patients might aggregate spontaneously,
lodge in the glomerular mesangium and be phlogogenic,
we have no evidence that touches on this. Third, IgA may
be present as an immunologic effector of the renal disease.
Mesangial localization of Ig is compatible with nephritis
caused by immune complexes [38, 39]. If these cases re-
present instances of immune complex-induced glomerulo-
nephritis, the dominant mesangial rather than peripherial
glomerular localization of ig would suggest that the com-
plexes are swept preferentially into the mesangium. Such
might occur if complexes are formed in antibody excess
[38].
IgA may participate in immune complexes either as
antigen or antibody. No circulating anibody to IgA was
found in the sera of these patients, however, including
one anephric patient (W. G.). Conversely, the likelihood
that IgA exists as an antibody to a common antigen, IgG,
also seems unlikely. In three biopsies, IgG was not identi-
fied. Furthermore, in one biopsy from the present series
and five similar IgA-containing biopsies obtained more
recently and tested with aggregated, fluoresceinated human
IgG, no binding of fluoresceinated aggregates to glomerular
IgA was detected.
The specific fixation of IgA in eluate W. G. to mesangial
components of normal human kidney slices suggests the
possibility of another, previously unrecognized mechanism
of immunologic glomerular injury. This mechanism implies
that antibody specificity be directed towards mesangial
glomerular components, rather than at GBM. Maurer et al
[40] have described a model wherein a "planted," hetero-
logous antigen may serve as the focus for autologous anti-
bodies, exciting a vigorous glomerulonephritis, but
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spontaneous [41] or induced autoantibody against non-
basement membrane glomerular antigens has not been
described previously. Although rare human sera have been
observed [42] which will bind in vitro to homologous
glomerular mesangial components, quantitative binding to
squirrel monkey kidney in vivo was not observed in one
such case tested. Further observations with other eluates
will be required to establish definitive conclusions. That
binding of IgA was not observed with eluates from the
needle biopsies cannot be interpreted too strictly; the eulate
volumes did not permit quantitative analyses of immuno-
globulin harvests.
Three of the patients studied had subnormal concentra-
tions of serum lllC measured by immunodiffusion. All
had plentiful C'! q, inferred from double diffusion analyses
in agarose, at the time. The relevance of these observations
to the activity of the clinical glomerulonephritis process
[43, 44] cannot be assessed by our data.
In summary, we found no clincal, historical or epi-
demiologic evidence in these patients for a discrete, in-
citing, nephritogenic event, or consistent evidence of auto-
immune phenomena, cryoprecipitates, circulating anti-
bodies to IgA or biopsy-bound antibody activity against
aggregated, homologous IgG. IgA in an eluate from one
kidney, containing only IgA by direct immunofluorescence,
fixed in vitro to human kidney slices, fixation not observed
with that patient's serum IgA. The certain significance of
this isolated observation awaits further studies and con-
firmation. It is our opinion that IgA is pathogenetically
involved in the nephritis of these patients because of the
uniformity of IgA distribution in involved kidneys, its
presence with or without other immunoglobulin or serum
proteins and its selective detection in a minority of kidneys
examined.
Reprint requests to Dr. David C. Lowance, whose present ad-
dress is Division of Nephrology, Department of Medicine, Uni-
versity of Virginia School of Medicine, Charlottesville, Virginia
22904, U.S.A.
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